DNA Methylation Market is predicted to be US$ 5815.49 Million at a CAGR of 15% by 2033 | FMI Analyst

During the forecast period 2023-2033, the DNA Methylation Market is expected to grow at a value of 15% CAGR, according to Future Market Insights. By the year 2033, the global market for DNA methylation is expected to rise up to a market valuation of US$ 5815.49 Million. Furthermore, the growing prevalence of esophageal adenocarcinoma has contributed to …

Aesthetic Medical Devices Market expected to reach a valuation of US$ 35 Billion at a CAGR of 9.6% by 2032 | FMI Report

A recently published study by FMI expects the global Aesthetic Medical Devices Market to augment at a 9.6% CAGR from 2022 to 2032. By the end of the said assessment period, a valuation of US$ 35000 Million is expected for the market. The increase may be attributed mostly to the increased development of technologically advanced …

Cardiovascular Ultrasound Market is expected to reach a US$ 2.6 billion valuation by 2032 | FMI Study

The Cardiovascular Ultrasound market revenues were estimated at US$ 1.2 Billion in 2021 and is anticipated to grow at a CAGR of 7.2% from 2022-2032, according to a recently published Future Market Insights report. By the end of 2032, the market is expected to reach US$ 2.6 Billion. The market is predicted to grow as …

Liver Fibrosis Treatment Market is expected to reach a valuation of US$ 46.65 Billion by 2033 | FMI

The global Liver Fibrosis Treatment Market is anticipated to exceed a remarkable valuation of US$ 16.43 billion in 2023, with a compound annual growth rate (CAGR) of 11% projected from 2023 to 2033. The rising prevalence of undesirable outcomes such as hepatitis B or C virus infection, an impaired immune system due to co-infection with …

Next Generation Immunotherapies Market is expected to reach a valuation of US$ 268.84 billion by 2033 | FMI Study

The global Next Generation Immunotherapies Market is estimated to exceed a spectacular valuation of US$ 268.84 billion in 2033, with a compound annual growth rate (CAGR) of 7.5% projected from 2023 to 2033. The vast majority of present immunotherapies, such as checkpoint inhibitors, seek to enhance the immune system’s adaptive response, precisely cytotoxic T cells, …

Endometrial Ablation Market in the United Kingdom is projected to expand at a CAGR of around 8.4% from 2023 to 2033 | FMI

The Endometrial Ablation Market revenues were estimated at US$ 3.4 Billion in 2023 and are anticipated to grow at a CAGR of 7.3% from 2022-2032, according to a recently published Future Market Insights report. By the end of 2032, the market is expected to reach US$ 6.8 Billion. The aggregate revenue from US and China …

Advanced Cancer Pain Management Market expected to reach US$ 11,540 million by 2033, growing at a 4.74% CAGR | FMI Report

The global Advanced Cancer Pain Management Market is anticipated to attain an impressive valuation of USD 7265.44 million in 2023 and is estimated to reach US$ 11,540 million by 2033, trailing a CAGR of 4.74 % during the forecast period. Rapid technological advancements in neuromodulation technique for treatment of neuropathic cancer pain, surging investment to …

Medical Face Shield Market is set to experience 11.0% CAGR by 2030

Future Market Insights’ report on the medical face shield market infers that the market shall surge at a whopping 11% CAGR throughout 2030. As the pandemic paralyzes the entire world, the production of medical face shields is only anticipated to take-off on a high growth trajectory. With no signs of any drug or vaccine on the horizon, …

Medical Mask Market is expected to 10.0% Y-o-Y to US$ 9.8 Billion in 2030

There has been an increasing demand for medical masks recently, creating an absolute opportunity for growth of the medical mask market.  A new Future Market Insights (FMI) report reveals that the global medical mask market will experience a major upturn post 2022, .Medical mask demand is anticipated to increase globally at a 10.0% Y-o-Y annual growth …

Generic Injectable Market is accelerating at a CAGR of 11.6% by 2033

The global generic injectable market is predicted to register a robust CAGR of 11.6% over the forecast period, as per FMI’s analysis. The industry’s size is anticipated to increase from US$ 1,07,419.72 million in 2023 to US$ 3,22,433.1 million by 2033 end. The rising geriatric population, along with the prevalence of chronic diseases, is projected to have a favorable impact on the growth …